CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-29 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +500 | $1.51 | $755 | 44,968 |
| 2020-12-29 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −500 | $24.10 | $12K | 44,468 |
| 2020-12-29 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −500 | 8,500 | ||
| 2020-11-30 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +500 | $1.51 | $755 | 44,968 |
| 2020-11-30 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −500 | $23.35 | $12K | 44,468 |
| 2020-11-30 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −500 | 9,000 | ||
| 2020-10-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +1,500 | $1.51 | $2K | 45,968 |
| 2020-10-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −1,500 | $20.69 | $31K | 44,468 |
| 2020-10-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −1,500 | 9,500 | ||
| 2020-09-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +500 | $1.51 | $755 | 44,968 |
| 2020-09-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −500 | $25.33 | $13K | 44,468 |
| 2020-09-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −500 | 11,000 | ||
| 2020-09-18 | Bonvini Ezio Sr VP, Research & CSO | Sale | −18,339 | $32.00 | $587K | 83,807 |
| 2020-09-17 | Bonvini Ezio Sr VP, Research & CSO | Sale | −44,512 | $29.88 | $1.3M | 102,146 |
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion | +13,849 | $16.00 | $222K | 13,849 |
| 2020-09-09 | Galbraith Kenneth Director | Sale | −13,849 | $27.11 | $375K | 0 |
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion | +6,924 | $20.15 | $140K | 6,924 |
| 2020-09-09 | Galbraith Kenneth Director | Sale | −6,924 | $27.11 | $188K | 0 |
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion · Stock Option (right to buy) | −13,849 | 0 | ||
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion · Stock Option (right to buy) | −6,924 | 0 |
Page 25 of 26 · 503 trades